The BrAIST study and the implications for scoliosis screening: our duty for raising awareness and advocacy
© Grivas et al; licensee BioMed Central Ltd. 2014
Published: 4 December 2014
A recently published NIH-funded study named “Bracing in Adolescent Idiopathic Scoliosis Trial” (BrAIST) affirmed the efficacy of bracing for moderate adolescent idiopathic scoliosis (AIS) and reduced surgical recommendations in braced patients. The implications of this study are numerous. BrAIST affirms the value of bracing, but also confirms the importance of wear time, and points to the need to assess compliance with compulsory utilization of brace monitors. Additionally, one of the key implications of the study relates to early detection, possibly heralding a new era for scoliosis screening policy adoption.
To engage and enlist the feedback and potential advocacy, on behalf AIS patients, of all persons involved in relevant state agencies, scientific organizations and health care professions.
After a short presentation of BrAIST results, its implications will be highlighted on a) brace treatment, b) the importance of compliance, c) the value of screening programs. Subsequently the current concepts and recommendations on screening will be analyzed.
Other (Advocacy/Awareness raising report).
This established bracing effectiveness, reducing the number of patients who progress to surgery, resulting in cost savings and great benefit for scoliotics, also calls for raising awareness and advocacy of all the involved related professionals. Awareness will be increased by familiarizing people with the a) history and geography of screening policies, b) current evidence about screening, c) impact of screening on frequency of surgical treatment and its negative discontinuation effects on patients, d) the analysis of evolving aim of screening, e) the encouragement for policy statement publications from professional organizations and governmental agencies regarding scoliosis screening, f) by legislating national program and g) by presentations in pertinent scientific meetings. The advocacy will be benefited by a) providing guidelines on setting up these programs, b) recommendations for improvement of a screening program and c) popularizing its additional benefits on its contribution to clinical research on IS aetiology.
Due to the fact that the implementation of screening programs is inextricably bonded to non-operative IS treatment, it is believed that this reported “BrAiST” trial will have further impact on IS management swinging the pendulum.
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.